Genetic testing by cancer site: Pancreas

Jennifer E. Axilbund, Elizabeth A. Wiley

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


It is estimated that 5% to 10% of pancreatic cancer is familial. Although there is evidence of a major pancreatic cancer susceptibility gene, the majority of families with multiple cases of pancreatic cancer do not have an identifiable causative gene or syndrome. However, a subset of pancreatic cancer is attributable to known inherited cancer predisposition syndromes, including several hereditary breast cancer genes (BRCA1, BRCA2, and PALB2), CDKN2A, hereditary pancreatitis, hereditary nonpolyposis colorectal cancer, and Peutz-Jeghers syndrome. In addition to explaining a proportion of familial pancreatic cancer, individuals with these conditions are at increased risk for pancreatic cancer. Relatives from familial pancreatic cancer kindreds without one of these identifiable syndromes may have as high as a 32-fold risk of pancreatic cancer, depending on the number of affected first-degree relatives. Such high-risk individuals may benefit from increased surveillance, and strategies for early detection of pancreatic cancer are under evaluation.

Original languageEnglish (US)
Pages (from-to)350-354
Number of pages5
JournalCancer Journal (United States)
Issue number4
StatePublished - Jul 2012


  • familial cancer
  • genetics
  • hereditary syndrome
  • Pancreatic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Genetic testing by cancer site: Pancreas'. Together they form a unique fingerprint.

Cite this